NDV Biology and Tropism Mechanisms: Newcastle Disease Virus

Newcastle Disease Virus – perhaps you have never heard this term before, and yet it has a remarkable story in cancer medicine. First discovered in the 1920s as a virus affecting poultry, researchers noticed decades later that Newcastle disease Virus NDV is harmless to humans but can selectively attack tumor cells and stimulate the immune system. Since the 1960s, scientists in Europe and the USA have therefore studied it as a so-called oncolytic virus, and German research groups played an important role in this development

At GermanyHealth, we help you understand how such immunotherapies are organized in Germany. Here, NDV-based treatments are offered by specialized clinics and practices as a complementary, individualized approach – always alongside, never instead of, conventional cancer care. Consequently, careful coordination matters: from the first consultation and review of your medical records to treatment planning and follow-up, everything is arranged for you in a clear and structured way.If you are currently exploring novel cancer treatment pathways abroad,

GermanyHealth simplifies your direct access to Germany’s world-leading biological oncology network. Today, Germany is globally recognized for its meticulous organization of personalized immunotherapy, where safe therapies using NDV are routinely combined with tailored dendritic cell vaccines and local hyperthermia for optimal clinical results.

Why ICD with Newcastle Disease Virus is Necessary Before Receiving the Vaccine

Tumor cells frequently cloak themselves to evade detection, creating an immunological environment where your body’s defenses remain unaware of the threat. To create a powerful personalized vaccine, your dendritic cells need two vital elements: the exact antigen signature of your tumor and a strong biochemical alarm (the “danger signal”)

Here is why ICD immunogenic cell death therapy with Newcastle Disease Virus (NDV) plays an essential role in this process:

Releasing Target Antigens: When NDV causes selective tumor cell breakdown (oncolysis), it breaks open the cancer cells and exposes internal proteins. These antigens provide the precise template used to train the dendritic cells collected in Step 3. Read about “oncolytic virus”

Generating the “Danger Signal”: The viral activity mimics a natural infection around the tumor, releasing alarm signals that awaken dormant immune cells. This transforms quiet, unresponsive tissue into an active immune response site.

By combining the monocytes gathered during blood collection with the antigens and alarm signals generated by NDV therapy, your personalized vaccine gains the exact specificity required to mobilize your T-cells effectively against the disease.
.

See clinical trials of Newcastle Disease Virus and the evidence behind

Step-by-Step treatment sequence guide

Germany is arguably the most important country in Newcastle Disease Virus cancer history, but essentially all of the German work is from the 1990s and 2000s,

However,tThe Immun-Onkologisches Zentrum Köln is where the German NDV lineage continues. Schirrmacher moved there after DKFZ, working with Wilfried Stücker and Stefaan Van Gool. Their approach, called Individualized Multimodal Immunotherapy, combines three elements: systemic oncolytic NDV, modulated electrohyperthermia, and IO-Vac®, a dendritic cell vaccine loaded with autologous tumor lysate and matured with NDV danger signals.

Clin Cancer Res 2(1):21–28. The adjuvant phase II in resected colorectal carcinoma, 57 patients receiving active specific immunization, 48 of them with ATV-NDV. Surgical Department, University Hospital Mannheim.

Lehner et al. 1990 — Cancer Immunol Immunother 32(3):173–178. The earlier postoperative vaccination study in curatively resected colorectal cancer. Free full text on PMC via PubMed.

Schirrmacher, Schlude, Weitz, Beckhove 2015 — Int J Oncol 46:71–77. The phase I of ATV-NDV plus the bispecific bsHN-CD28 fusion protein in 14 late-stage colorectal patients. Open access.

Glioblastoma (University of Heidelberg) Schneider et al. 2001 — the first ASI study in GBM, 11 patients versus 11 matched controls.

Schirrmacher 2005 — Cancer Immunol Immunother, the synthesis across the ATV-NDV trials. Free full text.

IDH1 wild-type GBM case series — the main clinical output, free full text.

Individualized Multimodal Immunotherapy, rationale and experience (2024) — open access.

Breaking Therapy Resistance (2019) — Schirrmacher, Van Gool and Stücker’s review of the whole Newcastle disease virus program from DKFZ through IOZK.

The Memory Effect of combined Immunotherapy

Imagine giving your immune system a permanent upgrade against cancer. When facing a tough diagnosis, standard treatments often focus only on the immediate fight. However, your body also needs a long-term defense strategy that keeps protecting you far into the future.

Fortunately, combining 2 to 4 cycles of dendritic cell therapy with oncolytic viro-therapy using the Newcastle disease virus creates a powerful synergy. The Newcastle disease virus selectively infects cancer cells, causing them to burst open and reveal key markers that were previously hidden from your immune defenses.

Dendritic cells act as your body’s master intelligence officers. They gather these revealed cancer markers and present them directly to your T-cells, effectively training your immune army to recognize the enemy with pinpoint precision.

As a result, going through 2 to 4 targeted cycles unlocks what scientists call the “memory effect.” Instead of forgetting the threat once treatment pauses, your T-cells store the unique signature of the tumor. They remain on high alert throughout your bone marrow, ready to hunt down lingering or returning cancer cells indefinitely.

This combined approach of dendritic cell therapy and viral therapy offers more than a temporary shield—it builds a lasting immune memory to guard your health for the long haul.

Type of cancers we treat with Immunotherapy

Find a clinic for Immunotherapy in Germany

Germany is renowned for its advanced medical treatments and state-of-the-art facilities, making it a top destination for patients seeking cutting-edge therapies like comprehensive immunotherapy with the Newcastle disease virus. One of the leading organizations in this field is GermanyHealth.

Our offer includes all from A to Z including transportation if you need it. Hence, for a remote second opinion, book here. However, if you have high demand, we recommend booking our VIP Service Germany.

Also our patient service provides comprehensive support for international patients seeking treatment with dendritic cell vaccine for prostate cancer in Germany.

Expert Consultation and Treatment Planning: We provide expert medical consultation to determine the most appropriate treatment plan for each patient with prostate cancer to get the appropriate dendritic cell therapy.

Hospital and Clinic Coordination: We arrange treatment at some of Germany’s best hospitals and clinics specializing in the treatment of prostate cancer with modern Immunotherapies. Of course, you receive our onside service as well.

Travel and Accommodation Assistance: We assist with travel arrangements, visa applications, transportation in Germany, and accommodation, ensuring a smooth and stress-free experience.

Ongoing Patient Support: We offer continuous support throughout the treatment process, including follow-up care and communication with the clinic. Hence, we provide follow up service after you have left back home.

Newcastle Disease Virus